Press Releases

May 12, 2023

Comanche Biopharma Appoints Allyson Felix to Board of Directors

March 30, 2023

Comanche Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for CBP-4888, an siRNA Investigational Therapy for the Treatment of Preeclampsia

December 15, 2022

Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer

Media Contact

Jove Oliver
Oliver Global Communications
Mob: +1 646 373 4702